Table 3.

Hypoglycemia endpoints

	Baselinea	6 months	12 months
Symptomatic hypoglycemia
Incidence, n (%)	3 (4.8)	4 (6.5)	6 (9.7)
Events, n	15	6	15
Rate, events/patient year (95% CI)			0.23 (0.13, 0.38)
Severe hypoglycemia
Incidence, n (%)	1 (1.6)	0 (0)	1 (1.6)
Events, n	3	0	2
Rate, events/patient year (95% CI)			0.03 (0.00, 0.11)

^aBaseline hypoglycemia data refer to the 12-week period before baseline, i.e., before the start of Gla-300